Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Agilon Health (AGL) Other Operating Expenses (2020 - 2025)

Agilon Health's Other Operating Expenses history spans 6 years, with the latest figure at $1.7 billion for Q4 2025.

  • For Q4 2025, Other Operating Expenses rose 8.57% year-over-year to $1.7 billion; the TTM value through Dec 2025 reached $6.2 billion, up 33.0%, while the annual FY2025 figure was $6.2 billion, N/A changed from the prior year.
  • Other Operating Expenses reached $1.7 billion in Q4 2025 per AGL's latest filing, up from $1.5 billion in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of $1.7 billion in Q4 2025 to a low of -$5.5 million in Q2 2022.
  • Average Other Operating Expenses over 5 years is $988.5 million, with a median of $1.2 billion recorded in 2023.
  • Peak YoY movement for Other Operating Expenses: soared 84.22% in 2021, then tumbled 101.14% in 2022.
  • A 5-year view of Other Operating Expenses shows it stood at $151.0 million in 2021, then plummeted by 103.62% to -$5.5 million in 2022, then soared by 18100.05% to $982.4 million in 2023, then surged by 60.62% to $1.6 billion in 2024, then rose by 8.57% to $1.7 billion in 2025.
  • Per Business Quant, the three most recent readings for AGL's Other Operating Expenses are $1.7 billion (Q4 2025), $1.5 billion (Q3 2025), and $1.5 billion (Q2 2025).